Search Results - "Mirzaev, Karin B."

Supporting frontline clinicians in the time of the pandemic: Rapid response pharmacology team by Mirzaev, Karin B., Kiselev, Yury, Ivashchenko, Dmitriy V., Otdelenov, Vitaly, Sychev, Dmitry A.

Get full text

ADME pharmacogenetics: future outlook for Russia by Mirzaev, Karin B, Fedorinov, Denis S, Ivashchenko, Dmitry V, Sychev, Dmitry A

“…This systematic review reflects the results of pharmacogenetic studies in the Russian Federation aimed at studying the genes involved in the drug…”
Get full text

Pharmacogenetic markers of development of angioneurotic edema as a secondary side effect to enalapril in patients with essential arterial hypertension by Sychev, Ivan V, Denisenko, Natalia P, Kachanova, Anastasiya A, Lapshtaeva, Anna V, Abdullaev, Sherzod P, Goncharova, Ludmila N, Mirzaev, Karin B, Sychev, Dmitry A

“…Angioneurotic edema is the most dangerous complication in angiotensin-converting enzyme inhibitors (ACEIs) therapy. Based on the current data, the clinical and…”
Get more information

Genetic markers associated with resistance to radioiodine therapy in thyroid cancer patients: Prospective cohort study by Denisenko, Natalia P., Shuev, Grigorij N., Mukhamadiev, Reis H., Perfilieva, Oksana M., Kazakov, Ruslan E., Kachanova, Anastasia A., Milyutina, Olga I., Konenkova, Olga V., Ryzhkin, Sergey A., Ivashchenko, Dmitriy V., Bure, Irina V., Kirienko, Sergey L., Zhmaeva, Elena M., Mirzaev, Karin B., Ametov, Alexander S., Poddubnaya, Irina V., Sychev, Dmitry A.

“…Background. The indication for radiotherapy in oncological practice are metastases of differentiated thyroid cancer after thyroidectomy, the presence of…”
Get full text

CYP2C8, PTGS-1, 2 gene polymorphisms prevalence associated with sensitivity to non-steroidal anti-inflammatory drugs among North Caucasus ethnic groups by Abdullaev, Sherzod P., Denisenko, Natalia P., Mirzaev, Karin B., Shuev, Gregorii N., Sozaeva, Zhannet A., Kachanova, Anastasia A., Mammaev, Suleiman N., Kasaeva, Elvira A., Gafurov, Danial M., Grishina, Elena A., Sychev, Dmitry A.

“…Aim. Find the prevalence of CYP2C8*3 (rs10509681; rs11572080), PTGS-1 (rs10306135; rs12353214) and PTGS-2 (rs20417) alleles and genotypes in four ethnic groups…”
Get full text

CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome by Mirzaev, Karin B, Zelenskaya, Elena M, Barbarash, Olga L, Ganyukov, Vladimir I, Apartsin, Konstantin A, Saraeva, Natalya O, Nikolaev, Konstantin Y, Ryzhikova, Kristina A, Lifshits, Galina I, Sychev, Dmitry A

“…The aim of this study is to investigate the frequency of allelic variants, associated with poor response to clopidogrel, and , associated with excessive…”
Get full text

Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients? by Rytkin, Eric, Mirzaev, Karin B, Grishina, Elena A, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Giliarov, Michael Iu, Andreev, Denis A, Sychev, Dmitriy A

“…The aim of this study was to determine the impact of and gene polymorphisms and CYP3A4 isoenzyme activity on stent implantation complications among patients…”
Get full text

Evaluation of the association of CES1 (rs2244613) polymorphisms with the safety of remdesivir in hospitalized patients with COVID-19 by Temirbulatov, I. I., Kryukov, A. V., Mirzaev, K. B., Denisenko, N. P., Abdullaev, Sh. P., Kachanova, A. A., Sozaeva, Zh. A., Zhiryakova, A. S., Shevchuk, Yu. V., Vechorko, V. I., Averkov, O. V., Sychev, D. A.

“…Introduction . An outbreak of novel COVID-19 infection has become a real challenge for the entire human society, and first of all for the healthcare services…”
Get full text

The CES1 Gene rs2244613 Minor Allele Impact on the Safety Profile of Dabigatran Etexilate: Meta-Analysis by Abdullaev, S. P., Mirzaev, K. B., Bochkov, P. O., Sychev, I. N., Sychev, D. A.

“…Aim . A meta-analysis of studies on the CES1 gene c.1168-33A>C polymorphism (rs2244613) carriage influence on the equilibrium concentration and the risk of…”
Get full text

Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population by Mirzaev, K. B., Fedorinov, D. S., Ivashchenko, D. V., Sychev, D. A.

“…Aim. To summarize Russian studies using pharmacogenetic testing as applied to cardiology. Material and methods . The authors conducted an online search for…”
Get full text

Effect of polymorphisms in CYP3A422 (rs35599367) C>T, CYP3A53 (rs776746) A>G, ABCB1 (rs4148738) C>T and ABCB1 (rs1045642) C>T genes on apixaban anticoagulation: pilot study results by Sychev, I. N., Fedina, L. V., Osipov, A. S., Temirbulatov, I. I., Tataroy, O. Yu, Sozaeva, Zh. A., Akmalova, K. A., Denisenko, N. P., Abdullaev, S. P., Kachanova, A. A., Grishina, E. A., Mirzaev, K. B., Sychev, D. A.

“…Introduction . Apixaban is a direct oral anticoagulant prescribed for treatment and prevention of venous thromboembolism (VTE) and for prevention of stroke in…”
Get full text

Do CYP2C 19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients? by Rytkin, Eric, Mirzaev, Karin B, Grishina, Elena A, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Giliarov, Michael Lu, Andreev, Denis A, Sychev, Dmitriy A

“…Aim: The aim of this study was to determine the impact of CYP2C19 and ABCB1 gene polymorphisms and CYP3A4 isoenzyme activity on stent implantation…”
Get full text

Do CYP2C19 andABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients? by Rytkin, Eric, Mirzaev, Karin B, Grishina, Elena A, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Michael Iu Giliarov, Andreev, Denis A, Sychev, Dmitriy A

“…Aim: The aim of this study was to determine the impact of CYP2C19 and ABCB1gene polymorphisms and CYP3A4 isoenzyme activity on stent implantation complications…”
Get full text

New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants by Mirzaev, K. B., Ivashchenko, D. V., Volodin, I. V., Grishina, E. A., Akmalova, K. A., Kachanova, A. A., Skripka, A. I., Minnigulov, R. M., Morozova, T. E., Baturina, O. A., Levanov, A. N., Shelekhova, T. V., Kalinkin, A. I., Napalkov, D. A., Sokolova, A. A., Andreev, D. A., Sychev, I. N., Bochkov, P. O., Sychev, D. A.

“…Aim . To search for new pharmacogenetic biomarkers of bleeding risk in patients taking rivaroxaban and dabigatran for different indications: atrial…”
Get full text

The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty [Corrigendum] by Sychev, Dmitry, Levanov, Alexander, Shelekhova, Tatiana, Bochkov, Pavel Olegovich, Denisenko, Natalia, Ryzhikova, Kristina, Mirzaev, Karin B, Grishina, Elena, Gavrilov, Mikhail, Ramenskaya, Galina, Kozlov, Aleksei, Bogoslovsky, Tanya

“…Sychev DA, Levanov AN, Shelekhova TV, Bochkov PO, Denisenko NP, Ryzhikova KA, Mirzaev KB, Grishina EA, Gavrilov MA, Ramenskaya GV, Kozlov AV, Bogoslovsky T…”
Get full text

Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case by Andreyanova, M. A., Mirzaev, K. B., Sychev, D. A., Ryzhikova, K. A., Pokrovsky, A. V., Kharazov, A. F.

“…The considered clinical case of combination of multifocal atherosclerotic vascular lesion with type 2 diabetes mellitus and liver fibrosis demonstrates a…”
Get full text

Clinical and pharmacogenetic features of patients with upper gastrointestinal lesions at a multidisciplinary hospital: the role of nonsteroidal anti-inflammatory drugs by Denisenko, Natalia P, Zhiryakova, Anna S, Sychev, Ivan V, Kryukov, Alexander V, Tuchkova, Svetlana N, Vakulenko, Olga Y, Averkov, Oleg V, Vechorko, Valery I, Mirzaev, Karin B, Sychev, Dmitry A

“…Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly prescribed medications, but their use can be associated with a number of adverse…”
Get more information

MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring by Rytkin, Eric, Bure, Irina V, Bochkov, Pavel O, Akmalova, Kristina A, Mirzaev, Karin B, Cherniaeva, Marina S, Ostroumova, Olga D, Smirnov, Valery V, Grishina, Elena A, Saribekian, Anna G, Sychev, Igor N, Sychev, Dmitry A

“…The aim of this study is to assess micro-RNAs miR-142 and miR-39 as potential biomarkers for drug-monitoring of rivaroxaban among elderly patients with atrial…”
Get more information

Effects of the rs2244613 polymorphism of the CES1 gene on the antiplatelet effect of the receptor P2Y12 blocker clopidogrel by Mirzaev, Karin B, Osipova, Darya V, Kitaeva, Elena J, Shprakh, Vladimir V, Abdullaev, Sherzod P, Andreev, Denis A, Mumladze, Robert B, Sychev, Dmitriy A

“…Background The aim of this study was to evaluate the association of the carriage of the rs2244613 polymorphism of the CES1 gene with clopidogrel resistance as…”
Get more information

The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes by Mirzaev, Karin B, Rytkin, Eric, Ryzhikova, Kristina A, Grishina, Elena A, Sozaeva, Zhannet A, Fedorinov, Denis S, Konova, Olga D, Giliarov, Michael Iu, Belyakova, Galina A, Andreev, Denis A, Sychev, Dmitriy A

Get more information